JVP Jerusalem Venture Partners

Jerusalem Venture Partners is one of Israel’s longest-standing venture firms, founded by Erel Margalit, investing across cybersecurity, AI, foodtech, and selectively healthcare, with a thesis built around technically defensible Israeli founders and global category creation. The fund writes initial checks of roughly $2M to $10M from seed through Series B, can lead rounds, and has a track record including QlikTech and CyberArk. Healthcare exposure is partial and concentrated in healthcare AI, digital health software, and selectively medical devices where there is strong technical defensibility. AI focus is the primary thesis across the firm. Founders best suited are Israeli or Israeli-connected technical CEOs at seed through Series B in AI-enabled healthcare or cybersecurity for healthcare, with strong technical credentials and global ambition. Founders who do not fit include US-only digital health services, therapeutics, capital-intensive devices, and consumer wellness. Geographic preference is Israel and globally, with a strong US go-to-market angle expected. The entry path is warm introduction through an Israeli operator, a portfolio CEO, or a co-investor at funds like Pitango, Vintage, or 83North. LinkedIn outreach to a partner with a focused technical and global market summary is a reasonable secondary option. Expect deep technical diligence, scientific advisor reviews, and a long-term board partner who will engage on technical strategy and global market entry. Founders should plan for a thorough but supportive process and a partner that values ambition and technical depth.